Stocks / ADMA / Total Debt

ADMA Biologics, Inc. Total Debt 2011–2025

ADMA Biologics, Inc. reported $72.14M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.3% lower than fiscal 2024.

Latest filed value
$72.14M
One-year change
-0.3%
Change since 2020
Latest period end
2025
ADMA Biologics, Inc. Total Debt history from 2011 to 2025FY 2011: 0FY 2012: 0FY 2013: 0FY 2014: 0FY 2015: 0FY 2016: 1790000FY 2017: 2760000FY 2018: 2760000FY 2019: 0FY 2020: 0FY 2021: 0FY 2022: 0FY 2023: 0FY 2024: 72337000FY 2025: 72143000
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearTotal DebtChange (YoY)
FY 2025$72.14M-0.3%
FY 2024$72.34M
FY 2023$0
FY 2022$0
FY 2021$0
FY 2020$0
FY 2019$0-100.0%
FY 2018$2.76M+0.0%
FY 2017$2.76M+54.2%
FY 2016$1.79M
FY 2015$0
FY 2014$0
FY 2013$0
FY 2012$0
FY 2011$0

Source: ADMA Biologics, Inc. SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ADMA 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

ADMA Biologics, Inc. reported $72.14M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.3% lower than fiscal 2024. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for ADMA Biologics, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

ADMA Biologics, Inc. — frequently asked questions

What is ADMA Biologics, Inc.'s total debt (short- plus long-term borrowings)?

ADMA Biologics, Inc. (ADMA) reported total debt (short- plus long-term borrowings) of $72.14M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from ADMA Biologics, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.

More ADMA financial history

Full ADMA fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →